The end of one year... and the beginning of the next!

Well, it's very nearly that time of year already--the season of goodwill and the one week where we at FierceBiomarkers take a break. I'd like to take this opportunity to say thank you for researching biomarkers, developing biomarkers, and above all, reading about biomarkers in 2011. We'll be back in 2012 for what should be another exciting year. Happy holidays and enjoy! - Suzanne Elvidge (email)

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.